Congenital myopathies/dystrophies

Neurologic Clinics

Volumn 21, Issue 4, 2003, Pages 779-794

  Riggs, Jack E ^a   Bodensteiner, John B ^b   Schochet Jr , Sydney S ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL CORE DISEASE; CENTRONUCLEAR MYOPATHY; CHILD; CLINICAL FEATURE; DISEASE CLASSIFICATION; ELECTROMYOGRAPHY; HUMAN; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYOPATHY; NEMALINE MYOPATHY; ONSET AGE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

EID: 0142043301     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(03)00013-6     Document Type: Review

References (64)

1. Bodensteiner JB. Congenital myopathies. Muscle Nerve 1994;17:131-44.
2. Goebel HH. Congenital myopathies. Semin Pediatr Neurol 1996;3:152-61.
3. Riggs JE, Bodensteiner JB, Schochet SS. The dropped head sign: an unusual presentation of congenital myopathy. J Child Neurol 1994;9:330-1.
4. Shy GM, Magee KR. A new congenital non-progressive myopathy. Brain 1956;76:610-21.
5. Kausch K, Lehmann-Horn F, Janka M, Wieringa B, Grimm T, Muller CR. Evidence for linkage of the central core disease locus to proximal long arm of human chromosome 19. Genomics 1991;10:765-9.
6. Monnier N, Romero NB, Lerale J, Landrieu P, Fardeau M, Lunardi J. Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor. Hum Mol Genet 2001;10:2581-92.
7. Conen PE, Murphy EG, Donohue WL. Light and electron microscopic studies of "myogranules" in a child with hypotonia and muscle weakness. Canad Med Assn J 1963;89:983-6.
8. Shy GM, Engel WK, Somers JE, Wanko T. Nemaline myopathy. A new congenital myopathy. Brain 1963;86:793-810.
9. Norton P, Ellison P, Sulaiman AR, Harb J. Nemaline myopathy in the neonate. Neurology 1983;33:351-6.
10. Rifai Z, Kazee AM, Kamp C, Griggs RC. Intranuclear rods in severe congenital nemaline myopathy. Neurology 1993;43:2372-7.
11. Wallgren-Pettersson C, Rapola J, Donner M. Pathology of congenital nemaline myopathy. A follow-up study. J Neurol Sci 1988;83:243-57.
12. Gurgel-Giannetti J, Reed U, Bang ML, Pelin K, Donner K, Marie SK, et al. Nebulin expression in patients with nemaline myopathy. Neuromuscul Disord 2001;11:154-62.
13. Donner K, Ollikainen M, Ridanpaa M, Christen HJ, Goebel HH, de Visser M, et al. Mutations in the beta-tropomyosin (TPM2) gene-a rare cause of nemaline myopathy. Neuromuscul Disord 2002;12:151-8.
14. Wallgren-Pettersson C, Donner M, Sewry C, Bijlsma E, Lammens M, Bushby K, et al. Mutations in the nebulin gene can cause severe congenital nemaline myopathy. Neuromuscul Disord 2002;12:674-9.
15. Gurgel-Giannetti J, Bang ML, Reed U, Marie S, Zatz M, Labeit S, et al. Lack of the C-terminal domain of nebulin in a patient with nemaline myopathy. Muscle Nerve 2002;25:747-52.
16. Wattanasirichaigoon D, Swoboda KJ, Takada F, Tong HQ, Lip V, Iannaccone ST, et al. Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy. Neurology 2002;59:613-7.
17. Pelin K, Donner K, Holmberg M, Jungbluth H, Muntoni F, Wallgren-Pettersson C. Nebulin mutations in autosomal recessive myopathy: an update. Neuromuscul Disord 2002;12:674-9.
18. Spiro AJ, Shy GM, Gonatas NK. Myotubular myopathy: persistence of fetal muscle in an adolescent boy. Arch Neurol 1966;14:1-14.
19. Sher JH, Rimalovski AB, Athanassiades TJ, Aronson SM. Familial centronuclear myopathy: a clinical and pathological study. Neurology 1967;17:727-42.
20. Ambler MW, Neave C, Tutschka BG, Pueschel SM, Orson JM, Singer DB. X-linked recessive myotubular myopathy. I. Clinical and pathological findings in a family. Hum Pathol 1984;15:566-74.
21. Sawchak JA, Sher JH, Norman MG, Kula RW, Shafiq SA. Centronuclear myopathy heterogeneity: distinction of clinical types by myosin isoform patterns. Neurology 1991;41:135-40.
22. Strom EH, Tangsrud S-E. Craniopharyngioma in a boy with centronuclear (myotubular) myopathy: clinical and postmortem findings. Clin Neuropath 1986;5:84-7.
23. Thomas NS, Williams H, Cole G, Roberts K, Clarke A, Liechti-Gallati S, et al. X-linked neonatal centronuclear/myotubular myopathy: evidence for linkage to Xq28 DNA marker loci. J Med Genet 1990;27:284-7.
24. McEntagart M, Parsons G, Buj-Bello A, Biancalana V, Fenton I, Little M, et al. Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord 2002;12:939-46.
25. Junbluth H, Sewry CA, Buj-Bello A, Kristiansen M, Orstavik KH, Kelsey A, et al. Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation. Neuromuscul Disord 2003;13:55-9.
26. Hu LJ, Laporte J, Kress W, Dahl N. Prenatal diagnosis of X-linked myotubular myopathy: strategies using new and tightly linked DNA markers. Prenat Diagn 1996;16:231-7.
27. Samson F, Mesnard L, Heimburger M, Hanauer A, Chevallay M, Mercadier JJ, et al. Genetic linkage heterogeneity in myotubular myopathy. Am J Hum Genet 1995;57:120-6.
28. Heckmatt JZ, Sewry CA, Hodes D, Dubowitz V. Congenital centronuclear (myotubular) myopathy. A clinical, pathological and genetic study in eight children. Brain 1985;108:941-64.
29. McLeod JG, Baker W de C, Lethlean AK, Shorey CD. Centronuclear myopathy with autosomal dominant inheritance. J Neurol Sci 1972;15:375-87.
30. Engel AG, Gomez MR, Groover RV. Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin Proc 1971;46:666-81.
31. Rimmer KP, Whitelaw WA. The respiratory muscles in multicore myopathy. Am Rev Respir Dis 1993;148:227-31.
32. Kim JJ, Armstrong DD, Fishman MA. Multicore myopathy, microcephaly, agangionosis, and short stature. J Child Neurol 1994;9:275-7.
33. Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology 1969;19:591-605.
34. Nakagawa E, Ozawa M, Yamanouchi H, Sugai K, Goto Y, Nonako I. Severe central nervous system involvement in a patient with congenital fiber-type disproportion myopathy [letter]. J Child Neurol 1996;11:71-3.
35. Vestergaard H, Klein HH, Hansen T, Muller J, Skovby F, Bjorbaek C, et al. Severe insulin-resistant diabetes mellitus in patients with congenital muscle fiber type disproportion myopathy. J Clin Invest 1995;95:1925-32.
36. Danon MJ, Giometti CS, Manaligod JR, Swisher C. Sequential muscle biopsy changes in a case of congenital myopathy. Muscle Nerve 1997;20:561-9.
37. Gerdes AM, Petersen MB, Schroder HD, Wulff K, Brondum-Nielsen K. Congenital myopathy with fiber type disproportion: a family with a chromosomal translocation t(10-;17) may indicate candidate gene regions. Clin Genet 1994;45:11-6.
38. Brooke MH, Neville HE. Reducing body myopathy. Neurology 1972;22:829-40.
39. Oh SJ, Meyers GJ, Wilson ER, Alexander CB. A benign form of reducing body myopathy. Muscle Nerve 1983;6:278-82.
40. Carpenter S, Karpati G, Holland P. New observations in reducing body myopathy. Neurology 1985;35:818-27.
41. Engel AG, Angelini C, Gomez MR. Fingerprint body myopathy. A newly recognized congenital muscle disease. Mayo Clin Proc 1972;42:377-88.
42. Goebel HH. Desmin-related neuromuscular disorders. Muscle Nerve 1995;18:1306-20.
43. Reed L, Young J, Goebel HH, Schochet SS. Congenital cytoplasmic body myopathy. Case report. J Child Neurol 1997;12:149-52.
44. Nakano S, Engel AG, Waclawik AJ, Emslie-Smith AM, Busis NA. Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases. J Neuropath Exp Neurol 1996;55:549-62.
45. De Bleecker JL, Engel AG, Ertl BB. Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropath Exp Neurol 1996;55:563-77.
46. Dobkin BH, Verity MA. Familial neuromuscular disease with type I fiber hypoplasia, tubular aggregates, cardiomyopathy, and myasthenic features. Neurology 1978;28:1135-40.
47. Rohkamm R, Boxler K, Ricker K, Jerusalem F. A dominantly inherited myopathy with excessive tubular aggregates. Neurology 1983;33:331-6.
48. Martin JJ, Ceuterick C, Van Goethem G. On a dominantly inherited myopathy with tubular aggregates. Neuromuscul Disord 1997;7:512-20.
49. Brumback RA, Staton RD, Susag M. Exercise-induced pain, stiffness, and tubular aggregates in skeletal muscle. J Neurol Neurosurg Psychiat 1981;44:250-4.
50. Rosenberg NL, Neville HE, Ringel SP. Tubular aggregates, their association with neuromuscular disease, including the syndrome of myalgias/cramps. Arch Neurol 1985;42:973-6.
51. Oh SJ, Danon MJ. Nonprogressive congenital neuromuscular disease with uniform type I fiber. Arch Neurol 1983;40:147-50.
52. Connolly AM, Pestronk A, Planer GJ, Yuc J, Mehta S, Choksi R. Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining. Neurology 1996;46:810-4.
53. Kobayashi O, Hagashi Y, Arahata K, Ozawa E, Nonaka I. Congenital muscular dystrophy: clinical and pathological study of 50 patients with classical (Occidental) merosin-positive form. Neurology 1996;46:815-8.
54. Pegoraro E, Mancias P, Swerdlow SH, Raikow RB, Garcia C, Marks H, et al. Congenital muscular dystrophy with primary laminin α2 (merosin) deficiency presenting as inflammatory myopathy. Ann Neurol 1996;40:782-91.
55. Pegoraro E, Marks H, Garcia CA, Crawford T, Mancias F, Connolly AM, et al. Laminin alpha 2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology 1998;55:101-10.
56. Mercuri E, Yuva Y, Brown SC, Brockington M, Kinali M, Jungbluth H, et al. Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. Neurology 2002;58:1354-9.
57. Buttery PC, ffrench-Constant C. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 1999;14:199-212.
58. Toda T, Miyake M, Kobayashi K, Mizuno K, Saito K, Osawa M, et al. Linkage-dysequilibrium narrows the Fukuyama-type congenital muscular dystrophy (FCMD) candidate region to <100 kb. Am J Hum Genet 1996;59:1313-20.
59. Kondo-Iida E, Kobayashi K, Watanabe M, Saski J, Kumagai T, Koide H, et al. Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Hum Mol Genet 1999;8:2303-9.
60. Yamamoto T, Kato Y, Karita M, Takeiri H, Muramatsu F, Kobayashi M, et al. Fukutin expression in glial cells and neurons: implication in the brain lesions of Fukuyama congenital muscular dystrophy. Acta Neuropathol 2002;104:217-24.
61. Aida N, Tamagawa K, Takada K, Yagishita A, Kobayashi N, Chikumaru K, et al. Brain MR in Fukuyama congenital muscular dystrophy. Am J Neuroradiol 1996;17:605-13.
62. Toda T, Yoshioka M, Nakahori Y, Kanazawa I, Nakamura Y, Nakagome Y. Genetic identity of Fukuyama-type congenital muscular dystrophy and Walker-Warburg syndrome. Ann Neurol 1995;37:99-101.
63. Chadani Y, Kondoh T, Kamimura N, Matsumoto T, Matsuzaka T, Kobayashi O, et al. Walker-Warburg syndrome is genetically distinct from Fukuyama type congenital muscular dystrophy. J Neurol Sci 2000;177:150-3.
64. Cormand B, Pihko H, Baynes M, Valanne L, Santavuori P, Talim B, et al. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology 2001;56:1059-69.